When a lung cancer patient vomited black blood, it usually indicated that there was bleeding in the digestive tract. The specific length of life depended on the patient's physical condition, nutritional status, treatment, and whether they were actively treated. For early-stage lung cancer patients, after active and effective treatment, their normal lifespan would not be affected. For patients with lung cancer in the middle and late stages, if they were not treated effectively in time, they might be life-threatening due to tumor progression within 1-2 years. However, if the patient was actively treated and the progression of the disease was controlled, it might be possible to prolong the patient's survival time and even achieve a clinical cure. Therefore, the specific survival time varied from person to person, and it was impossible to determine an accurate number. For lung cancer patients, early detection, early diagnosis, and early treatment were the keys. At the same time, it was also important to maintain a good attitude.
Lung cancer would cause hemoptysis, not vomiting blood. Hemoptysis was caused by the inflammation of the lung cancer, which caused the respiratory tract to bleed. The blood was expelled from the body through coughing. The vomiting of blood was due to digestive tract bleeding, and had nothing to do with lung cancer. When a patient with lung cancer has symptoms of hemoptysis, they should seek medical treatment promptly, including bed rest, use of hemostatic drugs, and anti-inflammatory treatment. In rare cases, if medical treatment was ineffective, intervention surgery might be needed.
There could be many reasons for lung cancer patients to vomit black stuff. These reasons included blood clots, lung cancer, food and drug factors, and digestive tract bleeding. The specific situation needed to be determined according to the patient's condition and the doctor's diagnosis.
There were several possibilities for a patient with late-stage lung cancer to vomit dark brown vomit. One possibility was that it was caused by digestive tract bleeding. This could be because the bleeding from the lung cancer was not discharged in time, causing the blood to coagulate into old blood clots that were coughed out when coughing. The other possibility was that the necrotic tissue in the lung cancer had fallen off. In addition, vomiting dark brown vomit may also be related to side effects of drugs, tumor compression, abnormal liver function, and other factors. If the patient has such symptoms, it is recommended to seek medical advice in time for a clear diagnosis and targeted treatment according to the specific situation.
The survival time of patients with late-stage lung cancer who vomited black substance varied from person to person, usually around three to six months. However, the specific survival time depended on the severity of the patient's condition and whether they received timely treatment. If the condition is serious and not treated in time, the cancer cells may spread to other organs and tissues, thus affecting the safety of life. Active treatment and control of the progression of the disease, such as the use of drugs to suppress the growth of tumor cells or the use of a combination of chemotherapy and chemotherapy, may prolong the patient's survival. However, if effective measures are not taken in time to improve the symptoms and cause the disease to worsen, the patient's survival time may be shortened. Therefore, timely treatment and comprehensive management were crucial for patients with advanced lung cancer who vomited black substances.
The symptoms of hemoptysis in lung cancer were dark red or brown bloody phlegm, frequent hemoptysis, and hemoptysis after severe coughing. If the patient found that the color of hemoptysis was dark red or brown bloody phlegm, frequent and repeated hemoptysis, or sudden obvious hemoptysis during violent coughing, these may indicate that they may have lung cancer. However, the symptoms of hemoptysis alone could not determine whether it was lung cancer. Other preliminary screening methods, such as imaging, were needed. Therefore, one could not determine whether one had lung cancer just by coughing up blood.
The color of lung cancer hemoptysis was usually bright red or dark red. When the tumor invaded the bronchi and small blood vessels in the lungs, it was easy to cause coughing up blood. If there is old bleeding, it may be dark red with clots. Generally speaking, coughing up blood from lung cancer meant that the condition was more serious, and surgery was usually needed.
Spitting out black water did not necessarily mean lung cancer. Black water vomiting was usually caused by digestive tract bleeding or other pathological reasons. Lung cancer patients vomiting black water may be due to bleeding in the digestive tract or the release of tumor necrotic factor. However, spitting out black water from the mouth alone could not be used as a basis for the diagnosis of lung cancer. If there are symptoms of vomiting black water, it is recommended to seek medical advice in time for relevant examinations to confirm the diagnosis, and to carry out targeted treatment according to the specific situation.
In the late stage of lung cancer, repeated fever may be caused by cancer fever, inflammation infection, and other reasons. Cancer-related fever was caused by the malignant tumor cells themselves or the active substances secreted by them, and it was mostly a low fever (about 37 - 38 ° C). On the other hand, the patient's body resistance was low, and he was susceptible to bacteria or viral infection. In this case, the fever temperature was generally higher (above 38.5 ° C). The overall prognosis of lung cancer was poor, and the five-year survival rate might be less than 20%. Most patients with small cell lung cancer could survive for 6 to 12 months after treatment, while the one-year survival rate for patients with advanced non-small cell lung cancer was 15% to 35%. The survival period of different patients varied greatly, depending on their physical condition (such as whether they had underlying diseases such as chronic rheumatism, emphysis, cardiovascular and cerebral diseases), the condition of the tumor (such as the size of the tumor, distribution range, pathological type, degree of differentiation, etc.), whether the treatment was reasonable, whether the family members cooperated, whether the patient cooperated, and other factors. If the patient is in good health, can receive effective treatment (such as targeted immunity, chemotherapy, etc.) and can withstand the toxic and side effects of treatment, or if the patient has genetic mutations (such as mutations in genes such as ALK, Ecfrr, and RET), effective targeted drug therapy, and patients with high expression of POL1 (greater than 50%) may be able to prolong their survival through chemotherapy combined with immunity or simple immune therapy, even more than 5 years or 10 years. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
The incubation period of the disease could be as long as a few years, and it was even possible for the patient to not get sick for life. The incubation period of lung cancer was usually around 4-8 weeks, but some patients could have an incubation period of 2-3 months. Very few people might have a lifetime incubation period. Everyone's body constitution was different, so the incubation period was quite different. It was recommended to judge according to the specific situation. Lung cancer was a relatively common infectious disease of the lungs. It was highly contagious, with a high mortality rate. Patients with latent period or non-active period usually had no typical symptoms and were not contagious. The characteristics of the latent period also determined the uncertainty of the time of onset. Therefore, there was no fixed time for the incubation period of the disease. It was probably between a few months and a decade. The incubation period of lung cancer depends on the number and toxicity of the infected bacteria, as well as the resistance or immunity of the infected person.
The survival time of patients with lung cancer was affected by many factors, and it was difficult to give an exact number. If they did not receive any anti-cancer treatment, they would live for about three to four months on average. Advanced lung cancer was treated with targeted, chemotherapy, immunity, and other anti-tumor treatments. The average overall survival time of most patients was about two years. A small number of patients who were more sensitive to the above-mentioned anti-tumor therapy could achieve complete response and maintain stable progression after treatment. These patients could survive with tumors for a long time, reaching a survival period of five years or longer. According to the relevant research statistics, the reference data for the 5-year survival rate of non-small cell lung cancer in each stage was as follows: the 5-year survival rate of stage I non-small cell lung cancer was 70% - 90%, the 5-year survival rate of stage II was 50% - 70%, the 5-year survival rate of stage III-III was about 36%, 26% and 13% respectively, and the 5-year survival rate of stage IV lung cancer was only about 5%. The results of a national survey in Korea showed that the 5-year survival rate of non-small cell lung cancer was 82% in stage I, 59% in stage I, 16% in stage II, and 10% in stage IV. Regardless of whether it was early or late, the overall 5-year survival rate of small cell lung cancer was 16% in cases of limited diseases and 10% in cases of extensive diseases. The survival time after lung cancer spread was related to the pathological type, the mutation of the driver gene, the location of the tumor, whether it was treated, whether the treatment was standardized, whether the patient had complications, physical condition, age, economic status, and other factors. For example, if the lung cancer had brain metastasizing, if the lung cancer tumor was very small, the tumor in the lung would be one or two centimeters, and there would be no pathological changes. Brain metastasizing was an isolated and relatively small situation. After surgery, radiation therapy, and other treatments, many patients could survive for a long time. They might live for five years, or even ten or twenty years. Some patients with brain metastasizing might only live for a few months. If lung cancer spread to the bones, the patient could live for about six months under normal treatment, but the specific situation varied from person to person. If the patient's general condition was good, and there was only one part of the tumor that had metastasized, or if the metastasized was relatively mild, the patient's survival period might be more than two to three years. If the tumor had metastasized to multiple parts, and the patient could not eat, had anesthesia, consumed a lot of energy, and could not receive radiation and chemotherapy, the patient's survival period might only be a few months. The novel "Ten Years of Death" is equally exciting. Everyone is welcome to click and read it!